Hart Brett J 4

What Happened

• Brett J. Hart, a director of AbbVie Inc., received a grant of 1,118 restricted stock units (RSUs) reported as an award on 2026-05-08. The filing lists the acquisition price as $0.00 (typical for RSU awards), with a reported value of $0 on the Form 4 line item. This was an award (not a purchase or sale) — RSUs are a form of equity compensation rather than an open-market trade.

Key Details

• Transaction date: 2026-05-08; Form 4 filed: 2026-05-12 (filed after the transaction; Form 4s are generally required within two business days).
• Grant: 1,118 RSUs; price shown: $0.00; total per-line value: $0.
• Shares owned after the transaction: not specified in the details provided in this summary.
• Footnote: These RSUs are awarded under AbbVie’s 2013 Incentive Stock Program and will be delivered one-for-one in AbbVie common stock on the earlier of the director’s separation from service, death, or a change in control.
• Filing timeliness: The Form 4 was filed several days after the transaction date (appears late relative to the usual two-business-day requirement), meaning disclosure to the market was delayed.

Context

• RSUs are compensation grants that convert into shares under specified conditions and do not represent an immediate cash purchase or sale; they are common for directors and executives. Such awards are routine corporate compensation and should not be read as a direct market-buy signal.